| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002252A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA |
| 02/01/1996 | WO1996002243A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 02/01/1996 | WO1996002242A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 02/01/1996 | DE19527140A1 Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung Sprayable solutions with antihypertensive effect and process for their preparation and their use |
| 02/01/1996 | CA2195345A1 Use of (s)-adenosyl-l-methionine (same) and its physiologically compatible salts for treating reperfusion damage triggered by temporary focal ischaemia |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | CA2192478A1 Quinoline derivatives as leukotriene antagonists |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694537A1 Heterocyclyloxy- benzoylguanidine derivatives, their preparation and their use as inhibitors of the cellular Na+/H+-antiporter |
| 01/31/1996 | EP0694536A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them |
| 01/31/1996 | EP0694305A1 Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0694038A1 Novel androgens and anabolic agents |
| 01/31/1996 | EP0694033A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
| 01/31/1996 | EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | CN1115756A Method for preparing pharmaceutically active CNS compounds |
| 01/31/1996 | CN1115658A Chinese medicine composite for coronary heart disease and angina |
| 01/30/1996 | US5488145 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| 01/30/1996 | US5488059 N-cyano-n'-/1,1-dimethylpropyl/-n?-3-pyridinylguanidine |
| 01/30/1996 | US5488055 Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487888 Iron-binding polymers for oral administration |
| 01/30/1996 | CA2154906A1 Use of ifenprodil and diastereoisomers thereof for the preparation of medicines useful in the treatment of pheripheral neuropathies and central neurodegenerative diseases |
| 01/30/1996 | CA1338013C Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists |
| 01/26/1996 | CA2154129A1 Endothelin-antagonizing peptide |
| 01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001621A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | CA2170526A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693481A1 Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents |
| 01/24/1996 | EP0693474A1 Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof |
| 01/24/1996 | EP0693283A1 Heart failure remedy |
| 01/24/1996 | EP0693062A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 01/24/1996 | EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/24/1996 | EP0692984A1 Systemic effects of nitric oxide inhalation |
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/24/1996 | EP0579622B1 New phenol ethers, process for producing the same and medicaments containing these compounds |
| 01/24/1996 | EP0513285B1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| 01/24/1996 | CN1030766C Method for preparing of serotonin 5HTIA agonists |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/23/1996 | US5486532 Adrenergic agonist |
| 01/23/1996 | US5486531 Angina, hypotensive agents, erectile dysfunction |
| 01/23/1996 | US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase |
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/23/1996 | CA1337991C Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds |
| 01/23/1996 | CA1337973C Extracts of ginkgo biloba and their methods of preparation |
| 01/22/1996 | EP0700378A4 Compounds which release nitric oxide |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001253A2 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/18/1996 | WO1996001125A1 Use of insulin and igf-i |
| 01/18/1996 | DE4425280A1 Verwendung von (S)-Adenosyl-L-methionin (SAMe) und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die durch temporäre fokale Ischämie ausgelöst werden Use of (S) -Adenosyl-L-methionine (SAMe) and its physiologically acceptable salts for treating reperfusion damage triggered by temporary focal ischemia |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2193226A1 Use of insulin and igf-i |
| 01/18/1996 | CA2191775A1 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0692250A2 Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields |
| 01/17/1996 | EP0691985A1 Phosphonomethyldipeptides |
| 01/17/1996 | EP0691969A1 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | CN1115182A Antithrombotic |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 01/17/1996 | CN1114886A Bones and tendon recovery cream |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484942 Chemical intermediates for compounds that are antagonist for substance p such as analgesics, antiinflammatory agents, cns agents, antispasmodics or immunological effects |
| 01/16/1996 | US5484811 Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders |
| 01/16/1996 | US5484810 Tissue protective tocopherol analogs |
| 01/16/1996 | US5484804 Perhydroisoindole derivatives as antagonists of substance P |
| 01/16/1996 | US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484783 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
| 01/16/1996 | US5484780 Angiotensin II antagonists |
| 01/16/1996 | US5484775 Semisynthetic ganglioside analogues |
| 01/16/1996 | US5484774 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/14/1996 | CA2153720A1 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000736A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |